Samsung Biologics Market Cap

Samsung Biologics has a market cap or net worth of 69.62 trillion as of April 28, 2026. Its market cap has decreased by -9.68% in one year.

Market Cap

69.62T

Enterprise Value

68.92T

Revenue

4.81T

Ranking

n/a

PE Ratio

36.22

Stock Price

1,473,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 69.62T, an increase of 630.72%. That is a compound annual growth rate of 23.37%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	69.62T	-11.27%
Dec 30, 2025	78.46T	16.17%
Dec 30, 2024	67.54T	24.87%
Dec 28, 2023	54.09T	-7.43%
Dec 29, 2022	58.43T	-2.20%
Dec 30, 2021	59.75T	9.32%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Celltrion	43.39T
ALTEOGEN	20.15T
Samsung Epis Holdings	14.13T
HLB Co., Ltd.	8,357.72B
SK Biopharmaceuticals	8,034.94B
LigaChem Biosciences	7,415.45B
Peptron	6,307.34B
Voronoi	5,390.63B

Market Cap Rankings